Introduction
============

Deficient activation of protein kinase A (PKA) is a characteristic of T cells in systemic lupus erythematosus (SLE). A-kinase Anchoring Proteins (AKAPs) associate to and regulate the activity of PKA \[[@B1]\]. Furthermore, some AKAPs are expressed in T cells and influence their function \[[@B2]\]. Therefore, altered expression and/or function of AKAPs can play a role in the deregulated activity of PKA observed in SLE T cells.

Aims
====

To analyse the expression of different AKAPs in T cells isolated from SLE patients.

Patients and methods
====================

T cells were isolated by negative selection using magnetic beads from SLE patients (n= 12) and healthy controls (HC, n= 12). RNA was purified and levels of AKAP79, AKAP95 and AKAP450 mRNA were quantified by RT-qPCR. Subsequently, the analysis of AKAP79 expression was extended to include a total of 24 SLE patients and19 HC. In addition, AKAP79 protein was detected by Western Blot and quantified with Quantity One software.

Results
=======

Levels of AKAP450 mRNA were comparable in HC and SLE T cells (10.73 +/- 0.73 (HC, n= 12) vs 12.69 +/- 1.09 (SLE, n= 12), P= 0.15). However, T Cells from SLE patients had significantly higher levels of AKAP79 and AKAP95 mRNA than HC (AKAP79: 1.99 +/- 0.29 (HC, n= 19) vs 3.61 +/- 0.72 (SLE, n= 24), P= 0.04; AKAP95: 2.58 +/- 0.18 (HC, n= 12) vs 4.13 +/- 0.31 (SLE, n= 12), P= 0.0005). Analysis of AKAP79 protein levels showed increased levels of AKAP79 in SLE T cells compared to HC T cells (0.38 ± 0.05 (HC) vs 0.75 ± 0.18 (SLE), P= 0.06).

Conclusions
===========

Increased levels of AKAP79 and AKAP95 in T cells from SLE patients can contribute to the deregulation of PKA activity in these cells.
